UCA1 and neoplasm: Overexpression of UCA1 has been reported to be associated with resistance to chemotherapeutic drugs, including 5-fluorouracil, cisplatin, gemcitabine, paclitaxel, docetaxel, gefitinib, cetuximab, doxorubicin, daunorubicin, tamoxifen, temozolomide, and trastuzumab, in many kinds of tumor cells 65-80.